Genetic variation in the interleukin-1β-converting enzyme associates with cognitive function. The PROSPER study

Brain

Volumn 131, Issue 4, 2008, Pages 1069-1077

  Trompet, S ^a   De Craen, A J M ^a   Slagboom, P ^a   Shepherd, J ^b   Blauw, G J ^a   Murphy, M B ^c   Bollen, E L E M ^a   Buckley, B M ^c   Ford, I ^b   Gaw, A ^d   Macfarlane, P W ^e   Packard, C J ^b   Stott, D J ^b   Jukema, J W ^a   Westendorp, R G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c University College Cork and INFANT Centre   (Ireland)

^d NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^e Division of Cardiovascular and Medical Sciences

Author keywords

Cognitive function; Elderly; Inflammation; Interleukin 1beta converting enzyme

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PRAVASTATIN;

AGED; AGING; ALLELE; ARTICLE; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; LEARNING DISORDER; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; MENTAL PERFORMANCE; NEUROPROTECTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

AGED; AGED, 80 AND OVER; AGING; CASPASE 1; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-1BETA; LINKAGE DISEQUILIBRIUM; LONGITUDINAL STUDIES; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 41849088048     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn023     Document Type: Article

References (23)

1. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
2. Blankenberg S, Godefroy T, Poirier O, Rupprecht HJ, Barbaux S, Bickel C, et al. Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk. Circ Res 2006; 99: 102-8.
3. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005; 6: 167-70.
4. Dinarello CA, Savage N. Interleukin-1 and its receptor. Crit Rev Immunol 1989; 9: 1-20.
5. Gemma C, Fister M, Hudson C, Bickford PC. Improvement of memory for context by inhibition of caspase-1 in aged rats. Eur J Neurosci 2005; 22: 1751-6.
6. Gibertini M, Newton C, Friedman H, Klein TW. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun 1995; 9: 113-28.
7. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 7611-5.
8. Harel O, Zhou XH. Multiple imputation: review of theory, implementation and software. Stat Med 2007; 26: 3057-77.
9. Houx PJ, Shepherd J, Blauw GJ, Murphy MB, Ford I, Bollen EL, et al. Testing cognitive function in elderly populations: the PROSPER study. PROspective study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry 2002; 73: 385-9.
10. http://www-gene.cimr.cam.ac.uk/clayton/software. Assessed at 01-11-2007.
11. Lynch MA. Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Prog Neurobiol 1998; 56: 571-89.
12. Monraats PS, de Vries F, de Jong LW, Pons D, Sewgobind VD, Zwinderman AH, et al. Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention. Pharmacogenet Genomics 2006; 16: 747-54.
13. Murray CA, Clements MP, Lynch MA. Interleukin-1 induces lipid peroxidation and membrane changes in rat hippocampus: an age-related study. Gerontology 1999; 45: 136-42.
14. Oitzl MS, van Oers H, Schobitz B, de Kloet ER. Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res 1993; 613: 160-3.
15. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 1995; 18: 130-6.
16. Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci USA 1998; 95: 7778-83.
17. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360: 1623-30.
18. Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, et al. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol 1999; 84: 1192-7.
19. Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Todarello O, Pellicani V, et al. Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta 2006; 364: 91-112.
20. Spadaro F, Dunn AJ. Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav Immun 1990; 4: 308-22.
21. Thomson LM, Sutherland RJ. Systemic administration of lipopolysaccharide and interleukin-1beta have different effects on memory consolidation. Brain Res Bull 2005; 67: 24-9.
22. Wallenstein S, Hodge SE, Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 1998; 15: 173-81.
23. Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 2002; 50: 2041-56.